My News Resources

 DEALS     ENTER TO WIN     SHOP NOW    Ballistic Advantage Modern Series .223/5.56 16" M4 Barrel 1:7 Twist  Regular Price $152 Shop Now - $89.99    Ballistic Advantage Modern Series .223/5.56 16" Government Profile Barrel 1:7 Twist   Regular Price $156.75 Buy Now - $89.99    Ballistic Advantage .223/5.56 8" Barrel Pistol Length Gas System 1:7 Twist  Regular Price $114 Own Now - $79.99    Ballistic Advantage Performance Series .223/5.56 11.3" Barrel 1:7 Twist  Regular Price $199.50 Take It Home - $129.99    Ballistic Advantage Modern Series .308 Win 20" Heavy Barrel 1:10 Twist  Regular Price $237.50 Purchase Now - $139.99    Ballistic Advantage Performance

Also, U.S. life expectancy falls sharply and an expert offers fall gardening tips. View in browser | nytimes.com Continue reading the main story August 31, 2022 By Matthew Cullen Good evening. Here's the latest at the end of Wednesday. Vaccinations remain the cornerstone of the government's coronavirus strategy. Matt Rourke/Associated Press 1. The F.D.A. authorizes vaccines targeting Omicron. The agency's move marks the first approved redesign of coronavirus vaccines since they were rolled out in late 2020, setting the stage for millions of Americans to receive new booster doses as soon as next week . Two different vaccines aimed at the dominant BA.5 variant were cleared: one made by Pfizer for people as young as 12, and the other by Moderna, for those 18 and older. Only people who have received at least two shots and had at least two months since their last dose will be eligible for the updated booster. If you're confused about what to do, we asked experts to